| Nanoparticle–protein interactions: therapeutic approaches and supramolecular chemistry M Kopp, S Kollenda, M Epple Accounts of chemical research 50 (6), 1383-1390, 2017 | 166 | 2017 |
| Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer E Pastille, A Frede, HJ McSorley, J Gräb, A Adamczyk, S Kollenda, ... PLoS pathogens 13 (9), e1006649, 2017 | 56 | 2017 |
| Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation A Frede, B Neuhaus, T Knuschke, M Wadwa, S Kollenda, R Klopfleisch, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (8), 2395-2403, 2017 | 53 | 2017 |
| In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal … SA Kollenda, J Klose, T Knuschke, V Sokolova, J Schmitz, ... Acta biomaterialia 109, 244-253, 2020 | 42 | 2020 |
| A pH-sensitive fluorescent protein sensor to follow the pathway of calcium phosphate nanoparticles into cells S Kollenda, M Kopp, J Wens, J Koch, N Schulze, C Papadopoulos, ... Acta Biomaterialia 111, 406-417, 2020 | 33 | 2020 |
| A tumor-peptide–based nanoparticle vaccine elicits efficient tumor growth control in antitumor immunotherapy C Heße, S Kollenda, O Rotan, E Pastille, A Adamczyk, C Wenzek, ... Molecular cancer therapeutics 18 (6), 1069-1080, 2019 | 33 | 2019 |
| Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8+ T Cell Responses During Chronic … T Knuschke, O Rotan, W Bayer, S Kollenda, J Dickow, K Sutter, W Hansen, ... Frontiers in immunology 9, 614, 2018 | 24 | 2018 |
| Effective Activation of Human Antigen-Presenting Cells and Cytotoxic CD8+ T Cells by a Calcium Phosphate-Based Nanoparticle Vaccine Delivery System F Scheffel, T Knuschke, L Otto, S Kollenda, V Sokolova, C Cosmovici, ... Vaccines 8 (1), 110, 2020 | 19 | 2020 |
| Uptake of functional ultrasmall gold nanoparticles in 3D gut cell models V Sokolova, JF Ebel, S Kollenda, K Klein, B Kruse, C Veltkamp, ... Small 18 (31), 2201167, 2022 | 13 | 2022 |
| Using a specific RNA–protein interaction to quench the fluorescent RNA spinach L Roszyk, S Kollenda, S Hennig ACS chemical biology 12 (12), 2958-2964, 2017 | 13 | 2017 |
| A combination of anti-PD-L1 treatment and therapeutic vaccination facilitates improved retroviral clearance via reactivation of highly exhausted T cells T Knuschke, S Kollenda, C Wenzek, G Zelinskyy, P Steinbach, U Dittmer, ... mbio 12 (1), 10.1128/mbio. 02121-20, 2021 | 9 | 2021 |
| Silencing of proinflammatory NF-κB and inhibition of herpes simplex virus (HSV) replication by ultrasmall gold nanoparticles (2 nm) conjugated with small-interfering RNA N Wolff, S Kollenda, K Klein, K Loza, M Heggen, L Brochhagen, O Witzke, ... Nanoscale advances 4 (21), 4502-4516, 2022 | 6 | 2022 |
| Covalent attachment of aggregation-induced emission molecules to the surface of ultrasmall gold nanoparticles to enhance cell penetration K Klein, M Hayduk, S Kollenda, M Schmiedtchen, J Voskuhl, M Epple Molecules 27 (6), 1788, 2022 | 4 | 2022 |
| Tuning nanobodies’ bioactivity: Coupling to ultrasmall gold nanoparticles allows the intracellular interference with survivin P Stahl, S Kollenda, J Sager, L Schmidt, MA Schroer, RH Stauber, ... Small 19 (33), 2300871, 2023 | 3 | 2023 |
| Potentiating tweezer affinity to a protein interface with sequence-defined macromolecules on nanoparticles T Seiler, A Lennartz, K Klein, K Hommel, A Figueroa Bietti, I Hadrovic, ... Biomacromolecules 24 (8), 3666-3679, 2023 | 3 | 2023 |
| Reactivity of NK cells against ovarian cancer cells is maintained in the presence of calcium phosphate nanoparticles A Hrvat, M Schmidt, M Obholzer, S Benders, S Kollenda, PA Horn, ... Frontiers in Immunology 13, 830938, 2022 | 3 | 2022 |
| Vergleichende Studien Spinach-basierter FRET-Systeme am Beispiel der pp7-RNA-PP7-Protein Interaktion S Kollenda Technische Universität Dortmund Dortmund, 2015 | 1 | 2015 |
| Uptake of Functional Ultrasmall Gold Nanoparticles in 3D Gut Cell Models (Small 31/2022) V Sokolova, JF Ebel, S Kollenda, K Klein, B Kruse, C Veltkamp, ... Small 18 (31), 2270168, 2022 | | 2022 |
| Cetuximab-conjugated Nanoparticles as drug delivery systems. Distribution and biological effects on epithelial and mesenchymal cells in the head and neck area CP Eyth, S Hansen, K Bruderek, R Schirrmann, A Petra, K Wey, ... Laryngo-Rhino-Otologie 99 (S 02), 2020 | | 2020 |
| Cetuximab-konjugierte Nanopartikel als Drug-Delivery-System. Distribution und biologische Effekte auf epitheliale und mesenchymale Zellen im Kopf-Hals-Bereich CP Eyth, S Hansen, K Bruderek, R Schirrmann, A Petra, K Wey, ... Laryngo-Rhino-Otologie 99 (S 02), 2020 | | 2020 |
